Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Alen, Zabotti"'
Autor:
Alen Zabotti, Nicola Cabas, Sofia Cacioppo, Caterina Zoratti, Ivan Giovannini, Debora Berretti, Michele Maria Luchetti, Salvatore De Vita, Luca Quartuccio, Giovanni Terrosu, Marco Marino
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1321-1331 (2024)
Abstract Introduction Inflammatory bowel disease (IBD)-related arthritis is recognized as the most prevalent extraintestinal manifestation (EIM) of IBD. The objective of this study was to determine the prevalence and characteristics of undiagnosed IB
Externí odkaz:
https://doaj.org/article/01a14097693a4b90b5a725c488fa160c
Autor:
Andrea Picchianti Diamanti, Maria Sofia Cattaruzza, Simonetta Salemi, Roberta Di Rosa, Giorgio Sesti, Chiara De Lorenzo, Gloria Maria Felice, Bruno Frediani, Caterina Baldi, Maria Sole Chimenti, Arianna D’Antonio, Gloria Crepaldi, Michele Maria Luchetti, Valentino Paci, Alen Zabotti, Ivan Giovannini, Marco Canzoni, Giandomenico Sebastiani, Chiara Scirocco, Carlo Perricone, Bruno Laganà, Annamaria Iagnocco
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1347-1361 (2024)
Abstract Introduction Clinical remission is the main target in the management of patients with rheumatoid arthritis (RA). However, several authors found synovitis in patients with RA in clinical remission at ultrasonography (US). Upadacitinib is a se
Externí odkaz:
https://doaj.org/article/d17f65c67a4f4cf9999e97bded1dc1c1
Autor:
Abdulla Watad, Alen Zabotti, Yonatan Shneor Patt, Omer Gendelman, Arad Dotan, Niv Ben-Shabat, Lior Fisher, Dennis McGonagle, Howard Amital
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 4, Pp 963-976 (2024)
Abstract Introduction Biologic therapies are licensed for both psoriasis (PsO) and psoriatic arthritis (PsA) with some electronic medical record data suggest that IL (Interleukin)-23 blockers might be more protective in PsA prevention than TNF blocke
Externí odkaz:
https://doaj.org/article/7b8d8878a9ff404f81b9300439010617
Autor:
Laure Gossec, Josef S Smolen, Alen Zabotti, Georg Schett, Abdulla Watad, Dennis G McGonagle, Annarita Tullio, Salvatore De Vita, Ivan Giovannini, Enzo Errichetti, Ilaria Tinazzi, Luca Quartuccio, Ettore Silvagni, Filippo Fagni, Gabriele De Marco, David Simon, Michael Sticherling
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective Subjects with subclinical psoriatic arthritis (PsA), defined as the presence of arthralgia in psoriasis (PsO), are at higher risk of PsA but scant real-world data exist. Our aims were to (1) estimate the probability of PsA development in su
Externí odkaz:
https://doaj.org/article/8971c595d6de4d759a3c2abd481be74c
Autor:
Michele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, Alen Zabotti, Roberta Ramonda, Maria Sole Chimenti, Lorenzo Dagna, Nicoletta Luciano, Anna Piccinelli, Ivan Giovannini, Giovanni Striani, Nicola Boffini, Gilda Sandri, Niccolò Possemato, Ilenia Pantano, Devis Benfaremo, Carlo Salvarani, Francesco Ciccia, Carlo Selmi, Gianluca Moroncini
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Background Upadacitinib (UPA) is a selective JAK inhibitor recently approved for the treatment of psoriatic arthritis (PsA). In this post-approval study, we aimed to evaluate the effectiveness and safety of UPA over 24 weeks and identify cli
Externí odkaz:
https://doaj.org/article/108d482682b9424eb9e04468ca9fdd9d
Autor:
Enzo Errichetti, Alen Zabotti
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/421d76270c1648508c02ae12abd0c8c5
Autor:
Lorenzo Cereser, Filippo Marchesini, Emma Di Poi, Luca Quartuccio, Alen Zabotti, Chiara Zuiani, Rossano Girometti
Publikováno v:
Diagnostic and Interventional Radiology, Vol 28, Iss 6, Pp 569-575 (2022)
PURPOSETo evaluate the performance of radiology residents (RRs) when using a dedicated structured report (SR) template for chest HRCT in patients with suspected connective tissue disease-interstitial lung disease (CTD-ILD), compared to the traditiona
Externí odkaz:
https://doaj.org/article/e5c7611582b6487a8097ca85056c2ec9
Autor:
Laure Gossec, Annamaria Iagnocco, Xenofon Baraliakos, Daniel Aletaha, Josef S Smolen, Alen Zabotti, Dennis G McGonagle, Gabriele De Marco, Jenny Emmel, Paulo Gisondi
Publikováno v:
RMD Open, Vol 9, Iss 2 (2023)
Background Identifying subjects at risk of imminent psoriatic arthritis (PsA) would allow these subjects to participate in therapeutic interventions to delay or prevent PsA development.Methods A systematic literature review (SLR) was conducted in 202
Externí odkaz:
https://doaj.org/article/e10cbae6a9384d3baf78d8ce4c68abda
Autor:
Julio Ramírez, Pascal Richette, Alen Zabotti, Sarah Ohrndorf, Elke Theander, Marijn Vis, William Tillett, May Shawi, Wim Noël, Marlies Neuhold, Michel van Speybroeck, Miriam Zimmermann, Alexa Kollmeier
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objectives Psoriatic arthritis (PsA) phenotypes are typically defined by their clinical components, which may not reflect patients’ overlapping symptoms. This post hoc analysis aimed to identify hypothesis-free PsA phenotype clusters using machine
Externí odkaz:
https://doaj.org/article/420c72b2b3b04638a7ce97c7405459cb
Autor:
Pierluigi Macchioni, Antonio Marchesoni, Giovanni Ciancio, Gilda Sandri, Alen Zabotti, Gentiana Vukatana, Luca Montaguti, Mariacristina Focherini, Marcello Govoni, Amelia Spinella, Nazzarena Malavolta, Francesca Zuliani, Marco Bruschi, Fabio Mascella, Carlo Salvarani
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundIn psoriatic arthritis (PsA), low disease activity as defined by the Minimal Disease Activity (MDA) index is considered a good treatment target. However, as MDA is based only on clinical findings, it might not capture pauci-symptomatic infl
Externí odkaz:
https://doaj.org/article/ed8bd215f0b2455da0c2d286edc3ed5c